Sitaglap M 50 mg+1000 mg (Tablet)
Unit Price: ৳ 22.00 (2 x 10: ৳ 440.00)
Strip Price: ৳ 220.00
Medicine Details
Category | Details |
---|---|
Generic | Sitagliptin metformin hydrochloride |
Company | Euro pharma ltd |
Also available as |
Indications
- Adjunct to diet and exercise for type 2 diabetes mellitus
- Improves glycemic control in adults
Pharmacology
- Combines sitagliptin and metformin
- Dipeptidyl peptidase-4 (DPP-4) inhibitor
- Biguanide class member
- Mechanism of action on insulin and glucagon levels
- Regulation of glucose homeostasis
Dosage & Administration
- Individualized dosage
- Maximum recommended daily dose
- Twice daily administration
- Gradual dose escalation
- Incremental dosing for reduced side effects
- Maintenance of combination therapy
- Extended-release tablet dosing
- Co-administration with insulin
- Lower doses with other antihyperglycemic agents
Interaction
- Cationic drugs caution
- Phenprocoumon effect on anticoagulant
- Levothyroxine effect on hypoglycemia
Contraindications
- Renal disease or dysfunction
- Metabolic acidosis
- Hypersensitivity reaction
- Use with iodinated contrast materials
Side Effects
- Common adverse reactions
- Hypoglycemia incidence
- Hypoglycemia with insulin
- Adverse reactions with monotherapy
- Initiation adverse reactions of metformin therapy
Pregnancy & Lactation
- Pregnancy category B
- Use during pregnancy only if necessary
- Caution in nursing women
Precautions & Warnings
- Risk of lactic acidosis
- Monitoring of TSH levels
- Association with vitamin B12 level decrease
- Hepatic disease caution
- Renal function assessment
- Acute pancreatitis risk
- Hematologic parameter monitoring
- Limitation of alcohol intake
- Temporary insulin use during stress or decreased intake
- Allergic and hypersensitivity reactions
- No conclusive evidence of macrovascular risk reduction
Overdose Effects
- Supportive measures for sitagliptin
- Dialyzable nature of sitagliptin
- Overdose occurrences with metformin hydrochloride
- Dialyzable nature of metformin
- Pancreatitis risk
Therapeutic Class
- Combination oral hypoglycemic preparations
Storage Conditions
- Store below 25°C
- Dry place away from light
- Safety around children
- Use before expiry date
- Dispensed only on prescription
Related Brands
- Sitaglap M 50 mg+500 mg (Tablet) - euro-pharma-ltd
- Sitagil M 100 mg+1000 mg (Tablet (Extended Release)) - incepta-pharmaceuticals-ltd
- SB-Metsita 50 mg+500 mg (Tablet) - sunman-birdem-pharma-ltd
- SB-Metsita 50 mg+1000 mg (Tablet) - sunman-birdem-pharma-ltd
- Glucodip-M XR 50 mg+1000 mg (Tablet (Extended Release)) - sun-pharmaceutical-bangladesh-ltd